Acute injuries less than three months old typically respond fastest to BPC-157, while chronic tendinopathy that has been present for years may require longer treatment and tempered expectations
Summary IGF-1 LR3 solves a specific problem in IGF research: the short half-life of native IGF-1 due to IGFBP sequestration
NAD+ is a better first choice for patients whose primary complaints are energy depletion, brain fog, metabolic slowdown, or mood instability
What GHK-Cu adds to the formulation: Gene expression modulation across hundreds of genes including collagen genes (Type I, III), tissue inhibitors of metalloproteinases, anti-inflammatory mediators Collagen synthesis stimulation, specifically Type I and Type III collagen the structural proteins of skin, connective tissue, and many other tissues Anti-inflammatory signaling through investigated effects on TNF-, IL-6, and NF-B pathways Copper-peptide chemistry effects including cofactor activity for skin-relevant enzymes Skin-research and hair-research applications (the GHK-Cu literature in these areas is substantial) For the GHK-Cu deep-dive, see Copper Peptides Explained